Oncology Informatics Market Size, Type Analysis, Application Analysis, End-Use, Industry Analysis, Regional Outlook, Competitive Strategies And Forecasts, 2023-2032

  • Report ID: ME_0089937
  • Format: Electronic (PDF)
  • Publish Type:
  • Number of Pages: 250
Home Healthcare oncology informatics market....
  • Single User $3500
  • Multi User $4500
  • Enterprise User $5500
Report Description Request For TOC Research Methodology Download Free Sample

Market Snapshot

CAGR:9.43
2023
2032

Source: Market Expertz

RND-Favicon
Study Period 2019-2032
Base Year 2023
Forcast Year 2023-2032
CAGR 9.43
Healthcare-companies
Healthcare-Snapshot

Gain accurate insights regarding the negative impacts of COVID-19 on all markets and industries

Download Sample Pdf
Download Sample Pdf

Report Overview

Introduction: Oncology Informatics Market Study

The detailed market intelligence report on the Oncology Informatics Market applies the best of both primary and secondary research to weighs upon the competitive landscape and the prominent market players expected to dominate the Oncology Informatics Market for the forecast period, 2016 - 2026. The study not only scans through the company profile of the major vendors but also analyses their winning strategies to give business owners, stakeholders and field marketing personnel a competitive edge over others operating in the same space. A detailed evaluation of the major events such as acquisition and mergers, collaborations, product launches, new entrants, and technology advancements offer a complete overview of what the future of the Oncology Informatics Market will be like in the years to come.

Oncology Informatics Market is valued at USD 2.16 million in 2018 and is expected to cross USD 3.26 million by the end of 2026, growing at a CAGR of around 8% between 2020 and 2026.

Oncology Informatics Market report by Market Expertz provides results from an in-depth analysis built on a 360-degree research methodology where over 35 companies in the Oncology Informatics Market industry were evaluated. The team of industry analysts identified more than 10 industry leaders excelling at innovation, poised for growth and ripe for investment, and recognizes them with insight into their innovative offerings, projected growth rates, strengths and opportunities for the future.

Knowing the trends influencing the industry performance

Stakeholders, marketing executives and business owners planning to refer a market research report can use this study to design their offerings and understand how competitors attract their potential customers and manage their supply and distribution channels. When tracking the trends researchers have made a conscious effort to analyze and interpret the consumer behaviour. Besides, the research helps product owners to understand the changes in culture, target market as well as brands so they can draw the attention of the potential customers more effectively.

Extensive data on Oncology Informatics Market segmentation

The Oncology Informatics Market report divides the market of potential buyers into different groups, or segments/sub segments, based on various characteristics. The segments and sub segments identified contain buyer who are expected to respond or react similarly to certain products and services. The report further finds out consumers who share traits including similar expectations, interests, geography and needs. The segmentation sheds light on how some customers are likely to purchase a product or service than others to enable marketers allocate their focus as well as resource.

Oncology Informatics Market share

The report discovers market’s total sale that is generated by a particular firms over a time period. Industry experts calculate share by taking into account the product sales over a period and then dividing it by the overall sales of the Oncology Informatics Market industry over a defined period. Subject matter experts further use this metric to offer a general idea of the share and size of a firm and its immediate rivals. By providing an in-depth knowledge of the position a company as well as an entrepreneur holds in the Oncology Informatics.

Attracting the Oncology Informatics Market target audience

First, the comprehensive report finds out why customers need a certain product or service. The study focuses on what problems a certain product and service can solve. Apart from target demographics industry experts weigh up on the factors including audience type, as well as others vital attributes about the target customer segment.

The major players covered in this report are:

Cerner Corporation, Change Healthcare, Elekta AB, F.Hoffmann-La Roche Ltd., Hologic Inc., IBM Corporation, Inspirata Inc.,  Koninklijke Philips N.V., Laboratory Corporation of America Holdings, McKesson Corporation, MIM Software, Inc. Oncology Analytics, Inc. , PerkinElmer, Inc., RELX Group, Sirenas LLC,  UnitedHealth Group, Inc. , and Varian Medical Systems, Inc.

On the basis of Application, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into:

academic institutes and research centers, and hospitals and diagnostics laboratories.

How geography and sales fit together

The study works as a boon for all business owners trying to identify the exact size of the target audience in a specific geographic location. Oncology Informatics Market enables entrepreneurs to determine the regional market for their business expansion. The study answers the questions below:

  • Where do the requirements come from?
  • Where do non-potential customers reside?
  • What is the buying behaviour of the customers dwelling in a particular area?
  • What is the spending power of the customers in a specific region?

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering:

  • United States
  • Europe
  • China
  • Japan
  • Southeast Asia
  • India

We can also provide the customized separate regional or country-level reports, for the following regions:

North America, United States, Canada, Mexico, Asia-Pacific, China, India, Japan, South Korea, Australia, Indonesia, Singapore, Rest of Asia-Pacific, Europe, Germany, France, UK, Italy, Spain, Russia, Rest of Europe, Central & South America, Brazil, Argentina, Rest of South America, Middle East & Africa, Saudi Arabia, Turkey, Rest of Middle East & Africa

In this Oncology Informatics Market study, the years considered to estimate the market size of Oncology Informatics Market are as follows:

History Year: 2014-2018

Base Year: 2018

Estimated Year: 2018

Forecast Year 2019 to 2026

The study objectives of this Oncology Informatics Market report are:

  • To analyze and study the global Lanthanides sales, value, status and forecast (2016-2026);
  • To analyze the top players in North America, Europe, China, Japan, Southeast Asia and India, to study the sales, value and market share of top players in these regions.
  • Focuses on the key Oncology Informatics Market players, to study the sales, value, market share and development plans in future.
  • Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
  • To define, describe and forecast the market by type, application and region.
  • To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
  • To identify significant trends and factors driving or inhibiting the market growth.
  • To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
  • To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
  • To strategically profile the key players and comprehensively analyze their growth strategies

Key questions answered in the report

  • What will be the market size in terms of value and volume in the next five years?
  • Which segment is currently leading the market?
  • In which region will the market find its highest growth?
  • Which players will take the lead in the market?
  • What are the key drivers and restraints of the market’s growth?

Key coverage of the report

  • Regional demand estimation and forecast
  • Pre-commodity pricing volatility
  • Technological updates analysis
  • Location Quotients Analysis
  • Raw Material Sourcing Strategy
  • Competitive Analysis
  • Product Mix Matrix
  • Vendor Management
  • Cost Benefit Analysis
  • Supply chain optimization analysis
  • Patent Analysis
  • Carbon Footprint Analysis
  • R & D Analysis
  • Mergers and Acquisitions

Why buy?

  • Understand the demand for Oncology Informatics Market to determine the viability of the market.
  • Identify the developed and emerging markets where Oncology Informatics Market services are offered.
  • Identify the challenge areas and address them.
  • Develop strategies based on the drivers, trends and highlights for each of the segments.
  • Evaluate the value chain to determine the workflow and to get an idea of the current position where you are placed.
  • Recognize the key competitors of this market and respond accordingly.
  • Knowledge of the initiatives and growth strategies taken up by the major companies and decide on the direction for further growth.
  • Define the competitive positioning by comparing the products and services with the key players in the market.

Request customized copy of Oncology Informatics Market report

We are grateful to you for reading our report. If you wish to find more details of the report or want a customization, contact us. You can get a detailed information of the entire research here. If you have any special requirements, please let us know and we will offer you the report as you want.

   Executive Summary
   1    Product Definition
         1.1    Oncology Information System (OIS)
         1.2    Other Systems Used in Oncology Informatics
 
   2    Market Overview
         2.1    Current Market Scenario
         2.2    The Role of EHRs in Oncology
         2.3    Need for Integration of EHR and OIS
         2.4    Pricing Models for EHR Oncology Systems
         2.5    Consumer Preference for Different Pricing Models
 
   3    Scope of the Report
 
   4    Research Methodology
         4.1    Research Methodology
 
   5    Industry Analysis
         5.1    Industry Trends
         5.2    Regulatory Framework
                  5.2.1    Regulatory Framework in North America
                  5.2.2    Regulatory Framework in Europe
                  5.2.3    Regulatory Framework in Asia-Pacific
         5.3    Patent Analysis
 
   6    Competitive Landscape
         6.1    Market Share Analysis
         6.2    Key Developments and Strategies
                  6.2.1    Partnerships and Collaborations
                  6.2.2    Product Launches and Upgradations
                  6.2.3    Mergers and Acquisitions
                  6.2.4    Business Expansion
                  6.2.5    Others
         6.3    Product Mapping Analysis
 
   7    Market Dynamics
         7.1    Market Drivers
                  7.1.1    Increasing Cost of Cancer Care
                  7.1.2    Emphasis on Reduction in Medical Errors and Readmission Rates
                  7.1.3    Growing Number of Cancer Patients
                  7.1.4    Rising Adoption of Oncology-Specific EHRs
         7.2    Market Restraints
                  7.2.1    Shortage of Medical Oncologists
                  7.2.2    High Cost of Implementation of Oncology-Specific EMRs
                  7.2.3    Lack of Interoperability Among HIT Systems
                  7.2.4    Data Security Concerns
         7.3    Market Opportunities
                  7.3.1    Integration of Oncology Health Informatics with Blockchain
                  7.3.2    Investment Opportunities in Emerging Markets such as India, China, and Brazil
                  7.3.3    Collaborations with Precision Medicine Providers
                  7.3.4    Introduction of Solutions in Different Languages
 
   8    Global Oncology Informatics Market (by Type)
         8.1    Overview
         8.2    Electronic Health Records (EHRs)
                  8.2.1    Overview
                  8.2.2    Role of EHR in Oncology
                  8.2.3    Features of Oncology EHR
                  8.2.4    Oncology EHR: Product Description
                  8.2.5    Global Installation of Oncology EHR
         8.3    Population Health Management (PHM)
                  8.3.1    Overview
                  8.3.2    Role of PHM in Oncology
                  8.3.3    Features of Oncology PHM
                  8.3.4    Oncology PHM: Product Description
         8.4    Clinical Decision Support System (CDSS)
                  8.4.1    Overview
                  8.4.2    Role of CDSS in Oncology
                  8.4.3    Features of Oncology CDSS
                  8.4.4    Oncology CDSS: Product Description
                  8.4.5    Application of CDSS in Oncology
                  8.4.6    Global Installation of Oncology CDSS
         8.5    Drug Discovery and Development Informatics
                  8.5.1    Overview
                  8.5.2    Role of Drug Discovery and Development Informatics in Oncology
                  8.5.3    Drug Discovery and Development Informatics in Oncology: Product Description
                  8.5.4    Application of Drug Discovery and Development Informatics in Oncology
                  8.5.5    Global Installation of Oncology Drug Discovery and Development Informatics
         8.6    Image Analytics
                  8.6.1    Overview
                  8.6.2    Role and Benefits of Image Analytics in Oncology
                  8.6.3    Oncology Image Analytics: Product Description
                  8.6.4    Application of Image Analytics in Oncology
 
   9    Global Oncology Informatics Market (by End User)
         9.1    Overview
         9.2    Pharmaceutical Industry
         9.3    Life Science Industry
         9.4    Contract Research Organizations (CROs)
         9.5    Academic Institutes and Research Centers
         9.6    Others (Hospitals and Other Care Facilities)
 
   10    Global Oncology Informatics Market (by Region)
           10.1    Overview
           10.2    North America
                      10.2.1    U.S.
                                    10.2.1.1    Companies in the U.S. Oncology Informatics Market
                                    10.2.1.2    Government Initiatives
                                    10.2.1.3    CDSS in the U.S. Oncology Informatics Market
                                    10.2.1.4    Market Dynamics
                      10.2.2    Canada
                                    10.2.2.1    Degree of Adoption of EHRs
                                    10.2.2.2    Local Oncology Informatics Products
                                    10.2.2.3    Market Dynamics
           10.3    Europe
                      10.3.1    Germany
                                    10.3.1.1    Degree of Adoption of HIT Solutions
                                    10.3.1.2    Factors Impacting Oncology Informatics Market in Germany
                                    10.3.1.3    Market Dynamics
                      10.3.2    U.K.
                                    10.3.2.1    Degree of Adoption of Oncology Informatics
                                    10.3.2.2    Market Dynamics
                      10.3.3    France
                                    10.3.3.1    Degree of Adoption of EHR
                                    10.3.3.2    Status of Oncology Informatics
                                    10.3.3.3    Market Dynamics
                      10.3.4    Spain
                                    10.3.4.1    Degree of Adoption of Oncology Informatics
                                    10.3.4.2    Market Dynamics
                       10.3.5    Italy
                                    10.3.5.1    Degree of Adoption of HIT Solutions
                                    10.3.5.2    Factors Impacting Oncology Informatics Market in Italy
                                    10.3.5.3    Partnerships
                                    10.3.5.4    Market Dynamics
                      10.3.6    Rest-of-Europe
           10.4    Asia-Pacific
                      10.4.1    South Korea
                                    10.4.1.1    Degree of Adoption of HIT Solutions
                                    10.4.1.2    Oncology Informatics in South Korea
                                    10.4.1.3    Market Dynamics
                      10.4.2    Japan
                                    10.4.2.1    Degree of Adoption of HIT Solutions
                                    10.4.2.2    Implementation of Oncology Informatics
                                    10.4.2.3    Market Dynamics
                      10.4.3    China
                                    10.4.3.1    Degree of Adoption of HIT Solutions
                                    10.4.3.2    Partnerships
                                    10.4.3.3    Market Dynamics
                      10.4.4    India
                                    10.4.4.1    Degree of Adoption of HIT Solutions
                                    10.4.4.2    Initiatives for Oncology Informatics
                                    10.4.4.3    Market Dynamics
                      10.4.5    Australia
                                    10.4.5.1    Degree of Adoption of EHR
                                    10.4.5.2    Market Dynamics
                      10.4.6    Rest-of-Asia-Pacific
                                    10.4.6.1    Degree of Adoption of HIT Solutions in New Zealand
                                    10.4.6.2    Degree of Adoption of HIT Solutions in Malaysia
                                    10.4.6.3    Degree of Adoption of HIT Solutions in Singapore
                                    10.4.6.4    Market Dynamics
           10.5    Rest-of-the-World
                      10.5.1    U.A.E.
                                    10.5.1.1    Degree of Adoption of HIT Solutions
                                    10.5.1.2    Challenges
                                    10.5.1.3    Market Dynamics
                      10.5.2    Saudi Arabia
                                    10.5.2.1    Degree of Adoption of HIT Solutions
                                    10.5.2.2    Market Opportunities
                      10.5.3    Brazil
                      10.5.4    Mexico
                      10.5.5    South Africa
                      10.5.6    Rest-of-Rest-of-the-World
 
   11    Company Profiles
           11.1    Cerner Corporation
                      11.1.1    Company Overview
                      11.1.2    Role of Cerner Corporation in Global Oncology Informatics Market
                      11.1.3    Product Offerings
                      11.1.4    Financials
                      11.1.5    Key Insights about Financial Health of the Company
                      11.1.6    Recent Developments
                      11.1.7    SWOT Analysis
           11.2    Change Healthcare
                      11.2.1    Company Overview
                      11.2.2    Role of Change Healthcare in Global Oncology Informatics Market
                      11.2.3    Product Offerings
                      11.2.4    Recent Key Developments
                      11.2.5    SWOT Analysis
           11.3    Elekta AB
                      11.3.1    Company Overview
                      11.3.2    Role of Elekta AB in Global Oncology Informatics Market
                      11.3.3    Product Offerings
                      11.3.4    Financials
                      11.3.5    Key Insights about Financial Health of the Company
                      11.3.6    Recent Key Developments
                      11.3.7    SWOT Analysis
            11.4    F. Hoffmann-La Roche Ltd
                      11.4.1    Company Overview
                      11.4.2    Role of F. Hoffmann-La Roche Ltd in Global Oncology Informatics Market
                      11.4.3    Product Offering
                      11.4.4    Financials
                      11.4.5    Key Insights about Financial Health of the Company
                      11.4.6    Recent Developments
                      11.4.7    SWOT Analysis
            11.5    Hologic, Inc.
                      11.5.1    Company Overview
                      11.5.2    Role of Hologic, Inc. in Global Oncology Informatics Market
                      11.5.3    Product Offerings
                      11.5.4    Financials
                      11.5.5    Key Insights about Financial Health of the Company
                      11.5.6    Recent Developments
                      11.5.7    SWOT Analysis
            11.6    IBM Corporation
                      11.6.1    Company Overview
                      11.6.2    Role of IBM Corporation in Global Oncology Informatics Market
                      11.6.3    Product Offerings
                      11.6.4    Financials
                      11.6.5    Key Insights about Financial Health of the Company
                      11.6.6    Recent Developments
                      11.6.7    SWOT Analysis
            11.7    Inspirata, Inc.
                      11.7.1    Company Overview
                      11.7.2    Role of Inspirata, Inc. in Global Oncology Informatics Market
                      11.7.3    Product Offerings
                      11.7.4    Recent Key Developments
                      11.7.5    SWOT Analysis
            11.8    Koninklijke Philips N.V.
                      11.8.1    Company Overview
                      11.8.2    Role of Koninklijke Philips N.V. in Global Oncology Informatics Market
                      11.8.3    Product Offerings
                      11.8.4    Financials
                      11.8.5    Key Insights about Financial Health of the Company
                      11.8.6    Recent Developments
                      11.8.7    SWOT Analysis
            11.9    Laboratory Corporation of America Holdings
                      11.9.1    Company Overview
                      11.9.2    Role of Laboratory Corporation of America Holdings in Global Oncology Informatics Market
                      11.9.3    Product Offerings
                      11.9.4    Financials
                      11.9.5    Recent Key Developments
                      11.9.6    SWOT Analysis
          11.10   McKesson Corporation
                      11.10.1    Company Overview
                      11.10.2    Role of McKesson Corporation in Global Oncology Informatics Market
                      11.10.3    Product Offerings
                      11.10.4    Financials
                      11.10.5    Key Insights about Financial Health of the Company
                      11.10.6    Recent Development
                      11.10.7    SWOT Analysis
           11.11   MIM Software, Inc.
                      11.11.1    Company Overview
                      11.11.2    Role of MIM Software, Inc. in Global Oncology Informatics Market
                      11.11.3    Product Offerings
                      11.11.4    Recent Key Developments
                      11.11.5    SWOT Analysis
          11.12   Oncology Analytics, Inc
                      11.12.1    Company Overview
                      11.12.2    Role of Oncology Analytics, Inc.in Global Oncology Informatics Market
                      11.12.3    Product Offerings
                      11.12.4    Recent Developments
                      11.12.5    SWOT Analysis
          11.13   PerkinElmer, Inc.
                      11.13.1    Company Overview
                      11.13.2    Role of PerkinElmer Inc, in Global Oncology Informatics Market
                      11.13.3    Product Offerings
                      11.13.4    Financials
                      11.13.5    Key Insights about Financial Health of the Company
                      11.13.6    Recent Developments
                      11.13.7    SWOT Analysis
          11.14   RELX Group
                      11.14.1    Company Overview
                      11.14.2    Role of RELX Group in Global Oncology Informatics Market
                      11.14.3    Product Offerings
                      11.14.4    Financials
                      11.14.5    Recent Developments
                      11.14.6    SWOT Analysis
          11.15   Sirenas, LLC
                      11.15.1    Company Overview
                      11.15.2    Role of Sirenas, LLC in Global Oncology Informatics Market
                      11.15.3    Product Offerings
                      11.15.4    Recent Key Developments
                      11.15.5    SWOT Analysis
          11.16   UnitedHealth Group, Inc
                      11.16.1    Company Overview
                      11.16.2    Role of UnitedHealth Group, Inc in Global Oncology Informatics Market
                      11.16.3    Product Offerings for Oncology Informatics Market
                      11.16.4    Financials
                      11.16.5    Recent Developments
                      11.16.6    SWOT Analysis
          11.17   Varian Medical Systems, Inc
                      11.17.1    Company Overview
                      11.17.2    Role of Varian Medical Systems, Inc. in Global Oncology Informatics Market
                      11.17.3    Product Offerings
                      11.17.4    Financials
                      11.17.5    Key Insights about Financial Health of the Company
                      11.17.6    Recent Developments
                      11.17.7    SWOT Analysis
 

List of Tables

Table 1:    Products for End Users as per Area of Usage
Table 2:    Market Share of Different End Users, 2018 & 2025
Table 2.1:    EHR Systems Meeting ASCO-Defined Criteria
Table 2.2:    Comparison Between Different EHR Pricing Models
Table 2.3:    Pricing of Different Medical Oncology EHRs for Different Practice Sizes
Table 5.1:    Regulatory Framework/Act/Policy/Consortium/Standard for Oncology Informatics Market in North America
Table 5.2:    Regulatory Framework/Act/Policy/Consortium/Standard for Oncology Informatics Market in Europe
Table 5.3:    Regulatory Framework/Act/Policy/Consortium/Standard for Oncology Informatics Market in Asia-Pacific
Table 5.4:    Number of Patents Granted Across Different Regions
Table 6.1:    Partnerships and Collaborations, 2017-2019
Table 6.2:    Product Launches and Upgradations, 2017-2019
Table 6.3:    Mergers and Acquisitions, 2017-2019
Table 6.4:    Business Expansion, 2016-2019
Table 6.5:    Awards/Certifications/Funding/Approvals, 2017-2019
Table 6.6:    Providers of Oncology Informatics Products
Table 7.1:    Country-Wise Analysis of Adverse Events, 2016
Table 8.1:    Description of Various Oncology EHR
Table 8.2:    Global Installation of Oncology EHR in Leading Organizations
Table 8.3:    Oncology PHM and its Product Description
Table 8.4:    Oncology CDSS, Product Description
Table 8.5:    Application Areas of CDSS in Oncology
Table 8.6:    Global Installation of Oncology CDSS in Leading Organizations
Table 8.7:    Oncology Drug Discovery and Development Informatics and Product Description
Table 8.8:    Global Installation of Oncology Drug Discovery and Development in Leading Organizations
Table 8.9:    Oncology Image Analytics and Product Description
Table 10.1:    Adoption Rate of EHR Across Specialties in the U.S. Healthcare System, 2017
Table 10.2:    Other European Countries Market Share in 2018 and 2025
Table 10.3:    Presence of EHR and EMR Systems Across Different Private and Public Hospitals
Table 11.1:    Recent Developments: Cerner Corporation
Table 11.2:    Recent Developments: Change Healthcare Corporation
Table 11.3:    Recent Developments: Elekta AB
Table 11.4:    Recent Developments, F. Hoffmann- La Roche Ltd
Table 11.5:    Recent Developments: Hologic, Inc.
Table 11.6:    Recent Developments: IBM Corporation
Table 11.7:    Recent Developments: Inspirata, Inc.
Table 11.8:    Recent Developments: Koninklijke Philips N.V.
Table 11.9:    Recent Developments: Laboratory Corporation of America Holdings
Table 11.10:    Recent Developments: McKesson Corporation
Table 11.11:    Recent Developments, MIM Software, Inc.
Table 11.12:    Recent Developments: Oncology Analytics, Inc.
Table 11.13:    Recent Developments: PerkinElmer, Inc.
Table 11.14:    Recent Developments: RELX Group
Table 11.15:    Recent Developments: Sirenas, LLC
Table 11.16:    Recent Developments: United Health Group, Inc.
Table 11.17:    Recent Developments: Varian Medical Systems, Inc.

List of Figures

Figure 1:    Global Oncology Informatics Market, 2018-2025
Figure 2:    Market Dynamics
Figure 3:    Share of Different Strategies
Figure 4:    Market Share of Different Regions, 2019-2025
Figure 2.1:    Comparison of Direct Cost Between SaaS and On-Premise-Based Systems
Figure 2.2:    Comparison of Subscription License and Perpetual License Fee Structure
Figure 3.1:    Global Oncology Informatics Market: Market Segmentation
Figure 4.1:    Global Oncology Informatics Market Methodology
Figure 4.2:    Primary Research
Figure 4.3:    Secondary Research
Figure 4.4:    Data Triangulation
Figure 4.5:    Bottom-Up Approach (Segment-Wise Analysis)
Figure 4.6:    Assumptions and Limitations
Figure 4.7:    Factors Considered for Data Prediction and Modeling
Figure 5.1:    Advantages of Oncology Informatics
Figure 6.1:    Global Oncology Informatics Market Share (by Company)
Figure 6.2:    Global Oncology Informatics Market (Key development and strategies)
Figure 6.3:    Partnerships and Collaborations Share (by Company)
Figure 6.4:    Product Launches and Upgradations (by Company)
Figure 6.5:    Mergers and Acquisitions (by Company)
Figure 6.6:    Other Activities (Share)
Figure 6.7:    Product Mapping Analysis- Global Oncology Informatics Market
Figure 8.1:    Global Oncology Informatics Market, by Type
Figure 8.2:    Global Oncology EHR Market, 2018-2025
Figure 8.3:    Features of Oncology EHR
Figure 8.4:    Investment Plans of Healthcare Providers and Payers for Population Health Management Strategies
Figure 8.5:    Workflow of Population Health Management Strategy
Figure 8.6:    Global Oncology PHM Market, 2018-2025
Figure 8.7:    Features of Oncology PHM
Figure 8.8:    Workflow of CDSS in Clinical Setting
Figure 8.9:    Global Oncology CDSS Market, 2018-2025
Figure 8.10:    Features of Oncology CDSS
Figure 8.11:    Global Oncology Drug Discovery and Development Informatics Market, 2018-2025
Figure 8.12:    Global Oncology Image Analytics Market, 2018-2025
Figure 9.1:    End Users of Oncology Informatics Market
Figure 9.2:    Global Oncology Informatics Market (Pharmaceutical Industry), 2018-2025
Figure 9.3:    Global Oncology Informatics Market (Life Science Industry), 2018-2025
Figure 9.4:    Global Oncology Informatics Market (CROs), 2018-2025
Figure 9.5:    Global Oncology Informatics Market (Academic Institutes and Research Centers), 2018-2025
Figure 9.6:    Global Oncology Informatics Market (Hospitals and Other Care Facilities), 2018-2025
Figure 10.1:    Region-Wise Analysis of Global Oncology Informatics Market, 2018 and 2025
Figure 10.2:    North America Oncology Informatics Market, 2018-2025
Figure 10.3:    Factors Influencing North America Oncology Informatics Market
Figure 10.4:    U.S. Oncology Informatics Market, 2018-2025
Figure 10.5:    Canada Oncology Informatics Market, 2018-2025
Figure 10.6:    Prevalence Rate of Various Chronic Diseases in Canada
Figure 10.7:    Europe Oncology Informatics Market, 2018-2025
Figure 10.8:    Initiatives in Europe
Figure 10.9:    Factors Influencing Oncology Informatics in Europe
Figure 10.10:    Germany Oncology Informatics Market, 2018-2025
Figure 10.11:    Cancer Cases in Germany, by Type, 2018
Figure 10.12:    Distribution of Medical Treatment Errors in Germany, by Error Type, 2016,
Figure 10.13:    U.K. Oncology Informatics Market, 2018-2025
Figure 10.14:    Cancer Cases in U.K., by Type, 2018
Figure 10.15:    France Oncology Informatics Market, 2018-2025
Figure 10.16:    Cancer Cases in France, by Type
Figure 10.17:    Spain Oncology Informatics Market, 2018-2025
Figure 10.18:    Cancer Cases in Spain, by Type, 2018
Figure 10.19:    Italy Oncology Informatics Market, 2018-2025
Figure 10.20:    Cancer Cases in Italy, by Type, 2018
Figure 10.21:    Other European Countries Oncology Informatics Market, 2018-2025
Figure 10.22:    Asia-Pacific Oncology Informatics Market, 2018-2025
Figure 10.23:    Factors Influencing Oncology Informatics Market in Asia-Pacific
Figure 10.24:    South Korea Oncology Informatics Market, 2018-2025
Figure 10.25:    Japan Oncology Informatics Marker, 2018-2025
Figure 10.26:    China Oncology Informatics Marker, 2018-2025
Figure 10.27:    India Oncology Informatics Market, 2018-2025
Figure 10.28:    Australia Oncology Informatics Market, 2018-2025
Figure 10.29:    Other Asia-Pacific Countries Oncology Informatics Marker, 2018-2025
Figure 10.30:    Rest-of-the-World Oncology Informatics Market, 2018-2025
Figure 10.31:    Factors Influencing the Rest-of-the-World Oncology Informatics Market
Figure 10.32:    U.A.E. Oncology Informatics Market, 2018-2025
Figure 10.33:    Saudi Arabia Oncology Informatics Market, 2018-2025
Figure 10.34:    Brazil Oncology Informatics Market, 2018-2025
Figure 10.35:    Mexico Oncology Informatics Market, 2018-2025
Figure 10.36:    South Africa Oncology Informatics Market, 2018-2025
Figure 10.37:    Rest-of-rest-of-the-World Oncology Informatics Market, 2018-2025
Figure 11.1:    Cerner Corporation: Product Portfolio for Oncology Informatics Market
Figure 11.2:    Cerner Corporation: Overall Financials, 2016-2018
Figure 11.3:    Cerner Corporation.: Revenue (by Segment), 2016-2018
Figure 11.4:    Cerner Corporation.: Revenue (by Region), 2016-2018
Figure 11.5:    Cerner Corporation: R&D Expenditure, 2016-2018
Figure 11.6:    Change Healthcare:  Product Portfolio for Oncology Informatics Market
Figure 11.7:    Elekta AB: Product Portfolio for Oncology Informatics Market
Figure 11.8:    Elekta AB: Overall Financials ,2016-2018
Figure 11.9:    Elekta AB: Revenue (by Segment) ,2016-2018
Figure 11.10:    Elekta AB: Revenue (by Region) ,2016-2018
Figure 11.11:    Elekta AB: R&D Expenditure, 2016-2018
Figure 11.12:    F. Hoffmann-La Roche Ltd: Product Portfolio for Oncology Informatics Market
Figure 11.13:    F. Hoffmann-La Roche Ltd: Overall Financials, 2016-2018
Figure 11.14:    F. Hoffmann-La Roche Ltd: Revenue (by Segment), 2016-2018
Figure 11.15:    F. Hoffmann-La Roche Ltd: Revenue (by Region), 2017-2018
Figure 11.16:    F. Hoffmann-La Roche Ltd: Revenue (by Region), 2016
Figure 11.17:    F. Hoffmann-La Roche Ltd: R&D Expenditure, 2016-2018
Figure 11.18:    Hologic, Inc.: Product Portfolio for Oncology Informatics Market
Figure 11.19:    Hologic, Inc.: Overall Financials ,2017-2019
Figure 11.20:    Hologic, Inc.: Revenue (by Business Segment) ,2017-2019
Figure 11.21:    Hologic, Inc.: Revenue (by Region) ,2017-2019
Figure 11.22:    Hologic, Inc.: R&D Expenditure, 2017-2019
Figure 11.23:    IBM Corporation: Product Portfolio for Oncology Informatics Market
Figure 11.24:    IBM Corporation: Overall Financials ,2016-2018
Figure 11.25:    IBM Corporation: Revenue (by Business Segment) ,2016-2018
Figure 11.26:    IBM Corporation: Revenue (by Region) ,2016-2018
Figure 11.27:    IBM Corporation: R&D Expenditure, 2016-2018
Figure 11.28:    Inspirata, Inc.: Product Portfolio for Oncology Informatics Market
Figure 11.29:    Koninklijke Philips N.V.: Product Portfolio for Oncology Informatics Market
Figure 11.30:    Koninklijke Philips N.V.: Overall Financials, 2016-2018
Figure 11.31:    Koninklijke Philips N.V.: Revenue (by Segment), 2016-2018
Figure 11.32:    Koninklijke Philips N.V.: Revenue (by Region), 2016-2018
Figure 11.33:    Koninklijke Philips N.V.: R&D Expenditure, 2016-2018
Figure 11.34:    Laboratory Corporation of America Holdings: Product Portfolio for Oncology Informatics Market
Figure 11.35:    Laboratory Corporation of America Holdings: Overall Financials ,2016-2018
Figure 11.36:    Laboratory Corporation of America Holdings: Revenue (by Segment) ,2016-2018
Figure 11.37:    Laboratory Corporation of America Holdings: Revenue (by Region) , 2016-2018
Figure 11.38:    McKesson Corporation: Product Portfolio for Oncology Informatics Market
Figure 11.39:    McKesson Corporation: Overall Financials, 2016-2018
Figure 11.40:    McKesson Corporation: Revenue (by Segment), 2016-2018
Figure 11.41:    McKesson Corporation: Revenue (by Region), 2016-2018
Figure 11.42:    McKesson Corporation: R&D Expenditure, 2016-2018
Figure 11.43:    MIM Software, Inc.: Product Portfolio for Oncology Informatics Market
Figure 11.44:    Oncology Analytics, Inc.: Product Portfolio for Oncology Informatics Market
Figure 11.45:    PerkinElmer, Inc.: Product Portfolio for Oncology Informatics Market
Figure 11.46:    PerkinElmer, Inc.: Overall Financials, 2016-2018
Figure 11.47:    PerkinElmer, Inc.: Revenue (by Segment), 2016-2018
Figure 11.48:    PerkinElmer, Inc.: Revenue (by Region), 2016-2017
Figure 11.49:    PerkinElmer, Inc.: Revenue (by Region), 2018
Figure 11.50:    PerkinElmer, Inc.: R&D Expenditure, 2016-2018
Figure 11.51:    RELX Group: Product Portfolio for Oncology Informatics Market
Figure 11.52:    RELX Group: Overall Financials, 2016-2018
Figure 11.53:    RELX Group: Revenue (by Segment), 2016-2018
Figure 11.54:    RELX Group: Revenue (by Region), 2016-2018
Figure 11.55:    Sirenas, LLC: Product Portfolio for Oncology Informatics Market
Figure 11.56:    UnitedHealth Group Inc: Product Portfolio for Oncology Informatics Market
Figure 11.57:    UnitedHealth Group, Inc.: Overall Financials, 2016-2018
Figure 11.58:    UnitedHealth Group, Inc.: Revenue (by Segment), 2016-2018
Figure 11.59:    United Health Group, Inc.: Revenue (by Region), 2016-2018
Figure 11.60:    Varian Medical Systems, Inc.: Product Portfolio for Oncology Informatics Market
Figure 11.61:    Varian Medical Systems, Inc.: Overall Financials, 2016-2018
Figure 11.62:    Varian Medical Systems, Inc.: Revenue (by Segment), 2016-2018
Figure 11.63:    Varian Medical Systems, Inc.: Revenue (by Region), 2016-2018
Figure 11.64:    Varian Medical Systems, Inc.: R&D Expenditure, 2016-2018

 

RESEARCH METHODOLOGY

A research methodology is a systematic approach for assessing or conducting a market study. Researchers tend to draw on a variety of both qualitative and quantitative study methods, inclusive of investigations, survey, secondary data and market observation.

Such plans can focus on classifying the products offered by leading market players or simply use statistical models to interpret observations or test hypotheses. While some methods aim for a detailed description of the factors behind an observation, others present the context of the current market scenario.

Now let’s take a closer look at the research methods here.

Secondary Research Model

Extensive data is obtained and cumulated on a substantial basis during the inception phase of the research process. The data accumulated is consistently filtered through validation from the in-house database, paid sources as well reputable industry magazines. A robust research study requires an understanding of the overall value chain. Annual reports and financials of industry players are studied thoroughly to have a comprehensive idea of the market taxonomy.

Primary Insights

Post conglomeration of the data obtained through secondary research; a validation process is initiated to verify the numbers or figures. This process is usually performed by having a detailed discussion with the industry experts.

However, we do not restrict our primary interviews only to the industry leaders. Our team covers the entire value chain while verifying the data. A significant number of raw material suppliers, local manufacturers, distributors, and stakeholders are interviewed to make our findings authentic. The current trends which include the drivers, restraints, and opportunities are also derived through the primary research process.

Market Estimation

The market estimation is conducted by analyzing the data collected through both secondary and primary research. This process involves market breakdown, bottom-up and top- down approach.

Moreover, while forecasting the market a comprehensive statistical time series model is designed for each market. Macroeconomic indicators are considered to understand the current trends of the market. Each data point is verified by the process of data triangulation method to arrive at the final market estimates.

Final Presentation

The penultimate process results in a holistic research report. The study equips key industry players to undertake significant strategic decisions through the findings. The report encompasses detailed market information. Graphical representations of the current market trends are also made available in order to make the study highly comprehensible for the reader.

You can also purchase parts of this report. Do you want to check out a section wise price list?
Request for Special Pricing

Personalized Business Report Tailored to Your Requirements

  • Our expert analysts collaborate directly with you to comprehend your specific needs.
  • Get data on regions, segments, competitors, and vendors of your choice.
  • Information is presented in alignment with your exact preferences and formatting.
Request for customization
Report Snapshot
Free Sample Report

"Find new revenue generation opportunities"